Levena Biopharma
Pharmaceuticals, 4955 Directors Pl, San Diego, California, 92121, United States, 51-200 Employees
Phone Number: 18*********
Who is LEVENA BIOPHARMA
Levena Biopharma is a global ADC CRO/CDMO dedicated to advancing Antibody Drug Conjugate programs from discovery to the clinic and beyond. In 2013, Sorrento acquired Concortis Biosystems,...
Read More
-
Headquarters: 4955 Directors Pl, San Diego, California, 92121, United States
-
Date Founded: 2013
-
Employees: 51-200
-
Revenue: $5 Million to $10 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 5122
Does something look wrong? Fix it. | View contact records from LEVENA BIOPHARMA
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Levena Biopharma
Answer: Levena Biopharma's headquarters are located at 4955 Directors Pl, San Diego, California, 92121, United States
Answer: Levena Biopharma's phone number is 18*********
Answer: Levena Biopharma's official website is https://levenabiopharma.com
Answer: Levena Biopharma's revenue is $5 Million to $10 Million
Answer: Levena Biopharma's SIC: 5122
Answer: Levena Biopharma has 51-200 employees
Answer: Levena Biopharma is in Pharmaceuticals
Answer: Levena Biopharma contact info: Phone number: 18********* Website: https://levenabiopharma.com
Answer: Levena Biopharma is a global ADC CRO/CDMO dedicated to advancing Antibody Drug Conjugate programs from discovery to the clinic and beyond. In 2013, Sorrento acquired Concortis Biosystems, establishing Levena as an independent, wholly-owned subsidiary of Sorrento Therapeutics to offer the scientific community access to our leading-edge linkers, payloads, and site-specific conjugation technologies. Our mission is to collaboratively develop conjugates that maximize the therapeutic potential of our clients' native or engineered antigen-targeting biomolecular carriers (antibodies, proteins and nucleic acids) and advance precision medicine options for patients with unmet clinical needs. We welcome discussing your projects and our capabilities at our world-class facilities in: -- San Diego (R&D Headquarters, 2013) -- Suzhou (CMC and cGMP, 2017) Levena provides small and large scale proof-of-concept (POC) conjugation services as well as complete ADC characterization using advanced analytical tools such as HPLC (HIC, SEC, RP), iCIEF and LC-MS, quality assessment (Drug-to-Antibody Ratio, purity via SDS-PAGE, aggregation, endotoxin, residual drug) and in vitro pharmacology for cytotoxicity studies. Expanding on IP from Concortis starting in 2008, we continue to maintain and grow our comprehensive, in-house portfolio of leading-edge ADC solutions, enabling Levena's world-class chemistry & conjugation teams to efficiently deliver constructs with unsurpassed quality and therapeutic potential. Our proprietary and non-proprietary ADC solutions include Linkers, Payloads, L-P chemistries and site-specific conjugation platforms [C-LockTM, K-LockTM and C-LockTM/K-LockTM for dual-drug delivery], enabling efficient development of mechanistically-defined ADCs with exacting, reproducible performance for safety, efficacy and clinical success.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month